These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 29299119)

  • 41. Phosphatidylserine decarboxylase downregulation in uric acid‑induced hepatic mitochondrial dysfunction and apoptosis.
    Liu N; Huang L; Xu H; He X; He X; Cao J; Xu W; Wang Y; Wei H; Wang S; Zheng H; Gao S; Xu Y; Lu W
    MedComm (2020); 2023 Aug; 4(4):e336. PubMed ID: 37502610
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of two mitotane starting dose regimens in patients with advanced adrenocortical carcinoma.
    Kerkhofs TM; Baudin E; Terzolo M; Allolio B; Chadarevian R; Mueller HH; Skogseid B; Leboulleux S; Mantero F; Haak HR; Fassnacht M
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4759-67. PubMed ID: 24057287
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mitochondria-associated endoplasmic reticulum membrane (MAM) integrity is required for insulin signaling and is implicated in hepatic insulin resistance.
    Tubbs E; Theurey P; Vial G; Bendridi N; Bravard A; Chauvin MA; Ji-Cao J; Zoulim F; Bartosch B; Ovize M; Vidal H; Rieusset J
    Diabetes; 2014 Oct; 63(10):3279-94. PubMed ID: 24947355
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High (18)F-FDG uptake by the remaining adrenal gland four months after surgery and initiation of mitotane treatment in two patients with adrenocortical carcinoma.
    Mpanaka I; Lyra VD; Kaltsas G; Chatziioannou SN
    Hell J Nucl Med; 2011; 14(2):168-72. PubMed ID: 21761022
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High-dose mitotane strategy in adrenocortical carcinoma: prospective analysis of plasma mitotane measurement during the first 3 months of follow-up.
    Mauclère-Denost S; Leboulleux S; Borget I; Paci A; Young J; Al Ghuzlan A; Deandreis D; Drouard L; Tabarin A; Chanson P; Schlumberger M; Baudin E
    Eur J Endocrinol; 2012 Feb; 166(2):261-8. PubMed ID: 22048971
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mitotane levels predict the outcome of patients with adrenocortical carcinoma treated adjuvantly following radical resection.
    Terzolo M; Baudin AE; Ardito A; Kroiss M; Leboulleux S; Daffara F; Perotti P; Feelders RA; deVries JH; Zaggia B; De Francia S; Volante M; Haak HR; Allolio B; Al Ghuzlan A; Fassnacht M; Berruti A
    Eur J Endocrinol; 2013 Sep; 169(3):263-70. PubMed ID: 23704714
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intracellular trafficking of phospholipids: import of phosphatidylserine into mitochondria.
    Vance JE; Shiao YJ
    Anticancer Res; 1996; 16(3B):1333-9. PubMed ID: 8694499
    [TBL] [Abstract][Full Text] [Related]  

  • 48. PK11195, a ligand of the mitochondrial benzodiazepine receptor, facilitates the induction of apoptosis and reverses Bcl-2-mediated cytoprotection.
    Hirsch T; Decaudin D; Susin SA; Marchetti P; Larochette N; Resche-Rigon M; Kroemer G
    Exp Cell Res; 1998 Jun; 241(2):426-34. PubMed ID: 9637784
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A phase II trial of combination chemotherapy and surgical resection for the treatment of metastatic adrenocortical carcinoma: continuous infusion doxorubicin, vincristine, and etoposide with daily mitotane as a P-glycoprotein antagonist.
    Abraham J; Bakke S; Rutt A; Meadows B; Merino M; Alexander R; Schrump D; Bartlett D; Choyke P; Robey R; Hung E; Steinberg SM; Bates S; Fojo T
    Cancer; 2002 May; 94(9):2333-43. PubMed ID: 12015757
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phase II evaluation of cisplatin and etoposide followed by mitotane at disease progression in patients with locally advanced or metastatic adrenocortical carcinoma: a Southwest Oncology Group Study.
    Williamson SK; Lew D; Miller GJ; Balcerzak SP; Baker LH; Crawford ED
    Cancer; 2000 Mar; 88(5):1159-65. PubMed ID: 10699907
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mitotane enhances cytotoxicity of chemotherapy in cell lines expressing a multidrug resistance gene (mdr-1/P-glycoprotein) which is also expressed by adrenocortical carcinomas.
    Bates SE; Shieh CY; Mickley LA; Dichek HL; Gazdar A; Loriaux DL; Fojo AT
    J Clin Endocrinol Metab; 1991 Jul; 73(1):18-29. PubMed ID: 1675220
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cardiolipin profile changes are associated to the early synaptic mitochondrial dysfunction in Alzheimer's disease.
    Monteiro-Cardoso VF; Oliveira MM; Melo T; Domingues MR; Moreira PI; Ferreiro E; Peixoto F; Videira RA
    J Alzheimers Dis; 2015; 43(4):1375-92. PubMed ID: 25182746
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chiral effects in adrenocorticolytic action of o,p'-DDD (mitotane) in human adrenal cells.
    Asp V; Cantillana T; Bergman A; Brandt I
    Xenobiotica; 2010 Mar; 40(3):177-83. PubMed ID: 20044879
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development of a pharmacokinetic model of mitotane: toward personalized dosing in adrenocortical carcinoma.
    Kerkhofs TM; Derijks LJ; Ettaieb H; den Hartigh J; Neef K; Gelderblom H; Guchelaar HJ; Haak HR
    Ther Drug Monit; 2015 Feb; 37(1):58-65. PubMed ID: 24887633
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Translocator protein (18 kDa) ligand PK 11195 induces transient mitochondrial Ca2+ release leading to transepithelial Cl- secretion in HT-29 human colon cancer cells.
    Ostuni MA; Ducroc R; Péranzi G; Tonon MC; Papadopoulos V; Lacapere JJ
    Biol Cell; 2007 Nov; 99(11):639-47. PubMed ID: 17561806
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of mitotane on mouse ovarian follicle development and fertility.
    Innocenti F; Cerquetti L; Pezzilli S; Bucci B; Toscano V; Canipari R; Stigliano A
    J Endocrinol; 2017 Jul; 234(1):29-39. PubMed ID: 28450646
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy.
    Luton JP; Cerdas S; Billaud L; Thomas G; Guilhaume B; Bertagna X; Laudat MH; Louvel A; Chapuis Y; Blondeau P
    N Engl J Med; 1990 Apr; 322(17):1195-201. PubMed ID: 2325710
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Distribution, pharmacological characterization and function of the 18 kDa translocator protein in rat small intestine.
    Ostuni MA; Péranzi G; Ducroc RA; Fasseu M; Vidic B; Dumont J; Papadopoulos V; Lacapere JJ
    Biol Cell; 2009 Jul; 101(10):573-86. PubMed ID: 19392661
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy and safety of mitotane in the treatment of adrenocortical carcinoma: A retrospective study in 34 Belgian patients.
    Maiter D; Bex M; Vroonen L; T'Sjoen G; Gil T; Banh C; Chadarevian R
    Ann Endocrinol (Paris); 2016 Oct; 77(5):578-585. PubMed ID: 27063476
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Studies of the pharmacology of o,p'DDD in man.
    MOY RH
    J Lab Clin Med; 1961 Aug; 58():296-304. PubMed ID: 13773354
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.